Annual Congress: Hematologic Malignancies

2020-hem-web-header

NCCN 2021 Virtual Congress: Hematologic Malignancies™
Live Virtual Program was held Thursday, October 14, 2021 – Saturday, October 16, 2021

Save the Date! The NCCN 2022 Annual Congress: Hematologic Malignancies™ will take place Friday, October 14, 2022 – Saturday, October 15, 2022, in New York, New York.

Continuing Education

Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, led expert discussions on the latest advances, updates to the NCCN Guidelines®, and unique and challenging patient cases.

View Recorded Presentations

 

Topics Include:

  • Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
  • Debate – Response Milestones that Matter in Chronic Myeloid Leukemia: MMR vs. CCyR
  • Patient Case Studies and Panel Discussion: Leukemias
  • Mutational Landscape in Myeloproliferative Neoplasms: Implications on Prognosis and Clinical Management
  • Recommendations for Managing Adults with Histiocytic Neoplasms: New NCCN Guidelines
  • Newly Diagnosed Multiple Myeloma: How Many Drugs are Enough?
  • Maneuvering the Complex Web of Treatment Options for Relapsed/Refractory Multiple Myeloma
  • Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
  • Optimizing Treatment Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Minimal Residual Disease Assessment in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Is it Ready for Routine Clinical Practice?
  • Updates in the Management of Early-Stage Diffuse Large B-Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease
  • Patient Case Studies and Panel Discussion: Lymphomas
  • Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
  • Optimizing First-Line Therapy for Advanced Stage Classic Hodgkin Lymphoma

View Recorded Presentations


Accreditation

This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.


Related Programs

Recorded Presentations from the NCCN 2021 Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ are now available.

View Recorded Presentations

Supported by educational grants from AstraZeneca; Daiichi Sankyo; Gilead Sciences, Inc. and Kite, A Gilead Company; GlaxoSmithKline; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer Inc.; Seagen Inc. (formerly Seattle Genetics, Inc.); and Takeda. This educational activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported by independent medical education grants from ADC Therapeutics, Pharmacyclics LLC and Janssen and Jazz Pharmaceuticals. This activity is supported by an independent educational grant from Merck & Co., Inc. This activity is supported by an independent medical education grant from Bristol Myers Squibb. Provided by an independent medical education grant from MorphoSys.

 

Save the dates!

NCCN 2022 Annual Congress: Hematologic Malignancies™
New York Marriott Marquis • New York, New York
Friday, October 14, 2022 – Saturday, October 15, 2022

NCCN 2023 Annual Congress: Hematologic Malignancies™
Hilton San Francisco Union Square • San Francisco, California
Friday, September 22, 2023 – Saturday, September 23, 2023